COVID-19 surge: Take strict action against those hoarding, selling remdesivir on black market, Centre tells states

Union minister DV Sadananda Gowda added that he has chaired a meeting with the Union Pharma Secretary to review the availability of the antiviral drug used in the treatment of COVID-19

Press Trust of India April 20, 2021 00:06:13 IST
COVID-19 surge: Take strict action against those hoarding, selling remdesivir on black market, Centre tells states

Representational image. AP

New Delhi: State governments have been asked to take strict action against anyone found indulged in black marketing or hoarding of antiviral drug remdesivir, Chemicals and Fertilisers Minister D V Sadananda Gowda said on Monday.

The minister said he has also taken a meeting with the pharma secretary to review the availability of the antiviral drug which is used in the treatment of COVID-19 .

"Took a meeting with the Secretary (Pharma) to review availability of #Remdesivir. Government is in regular touch with manufacturers regarding this. Weekly production plans have been prepared in consultation with the manufacturers," Gowda tweeted.

Black marketing, hoarding of remdesivir is being strictly monitored and state governments have been advised to take strict action against those indulging in such malpractices, he added.

In another tweet, the minister said: "Manufacturers have agreed to ramp up production of #Remdesivir. Additional sites for production have been approved. Production to be doubled in coming weeks."

On Sunday, Minister of State of Chemicals and Fertilisers Mansukh L Mandaviya had tweeted that the government plans to double the production of remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19 .

The government has given permission to 20 plants to produce the antiviral drug, he had said.

Already, remdesivir is being rolled out of 20 plants in the country.

On Saturday, the National Pharmaceutical Pricing Authority (NPPA) had announced that the pharmaceutical companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have reduced the price of their respective brands of remdesivir injection (100mg/vial).

Updated Date:

also read

India sees record 4.14 lakh COVID-19 cases in 24 hrs; Karnataka, Goa, Telangana impose fresh curbs
India

India sees record 4.14 lakh COVID-19 cases in 24 hrs; Karnataka, Goa, Telangana impose fresh curbs

The governments of West Bengal, Maharashtra, and Tamil Nadu appealed to the Centre for an increased allocation of medical oxygen as cases rise

'Medical infra in shambles, don't be like ostrich with head in sand': Delhi HC to Kejriwal govt
India

'Medical infra in shambles, don't be like ostrich with head in sand': Delhi HC to Kejriwal govt

Another bench of Chief Justice DN Patel and Justice Jasmeet Singh sought response of the Centre and Delhi government on a plea alleging that the number of ICU and non-ICU beds in two dedicated COVID hospitals were slashed by more than half due to oxygen shortage

Maharashtra sees 34,848 COVID-19 cases, 960 deaths; active caseload drops below 5 lakh
India

Maharashtra sees 34,848 COVID-19 cases, 960 deaths; active caseload drops below 5 lakh

Of 960 fatalities reported on Saturday, 371 had occurred in the past 48 hours, 188 last week and the rest before that but were added to the toll on Saturday